Latest News

NHS Scotland treatment of CKD with finerenone accepted by SMC

Bayer has announced that Kerendia (finerenone, 10mg and 20mg), an oral, first-in-class non-steroidal, selective mineralocorticoid receptor (MR) antagonist, has been accepted for use within...

Features

VASBI team signals bold new course for the society

Patient engagement, strong research collaborations, an open and inclusive canvas and year-round specialised education, will guide the multidisciplinary Vascular Access Society of Britain and...

KDOQI vascular access guidelines: Opportunity or concern for clinical research?

Earlier this year, in an interview with Renal Interventions, Scott Trerotola (Philadelphia, USA) remarked that “guidelines are a research workbook for the next generation”....

Videos

 Hands-on training for medical, rather than surgical, juniors took centrestage at the first UK Kidney Week (UKKW; 7– 9 June, Birmingham, UK) with stations on peritoneal dialysis, central venous catheter placement using a state-of-the-art simulator, a “home-made” chicken model...

John Aruny

Aisha Shaikh

Matteo Tozzi